SS
CAPR icon

SBI Securities’s Capricor Therapeutics CAPR Stock Holding History

SBI Securities’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$150K Buy
4,943
+4,809
+3,589% +$128K ﹤0.01% 719
2025
Q4 		$3.87K Buy
134
+67
+100% +$875 ﹤0.01% 2126
2025
Q3 		$483 Sell
67
-36
-35% -$265 ﹤0.01% 2983
2025
Q2 		$1.02K Buy
103
+99
+2,475% +$1.05K ﹤0.01% 2669
2025
Q1 		$38 Buy
4
+2
+100% +$28 ﹤0.01% 3712
2024
Q4 		$28 Buy
+2
New +$35 ﹤0.01% 3761

Other funds holding CAPR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SBI Securities's CAPR Position: Q1 2026 in Review

SBI Securities increased its Capricor Therapeutics (CAPR) stake by 3,589% in Q1 2026, buying an estimated $128K and bringing the position to 4,943 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #719.

SBI Securities first reported a position in CAPR in Q4 2024 and has held it in 6 quarters since. 177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.

  • SBI Securities held 4,943 shares of Capricor Therapeutics worth $150K as of Q1 2026.
  • SBI Securities bought 4,809 Capricor Therapeutics shares in Q1 2026, an estimated $128K.
  • Capricor Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #719 holding.
  • SBI Securities first reported a position in Capricor Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.